Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts
暂无分享,去创建一个
[1] Dr. Eduard Rindfleisch,et al. Histologisches Detail zu der grauen Degeneration von Gehirn und Rückenmark. (Zugleich ein Beitrag zu der Lehre von der Entstehung und Verwandlung der Zelle.) , 1863, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.
[2] J. Murray. Prelude to the framing of a disease: multiple sclerosis in the period before Charcots Leçons. , 2004, International MS journal.
[3] B. Trapp. Pathogenesis of multiple sclerosis: The eyes only see what the mind is prepared to comprehend , 2004, Annals of neurology.
[4] M. Barnett,et al. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.
[5] A. Compston. Genetic Susceptibility and Epidemiology , 2004 .
[6] A. Thompson,et al. Primary progressive multiple sclerosis: a 5-year clinical and MR study. , 2003, Brain : a journal of neurology.
[7] David H. Miller,et al. A controlled trial of natalizumab for relapsing multiple sclerosis. , 2003, The New England journal of medicine.
[8] Marco Rovaris,et al. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. , 2002, Archives of neurology.
[9] D. Gilden. A search for virus in multiple sclerosis. , 2002, Hybridoma and hybridomics.
[10] G. Comi,et al. In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. , 2001, Brain : a journal of neurology.
[11] G J Barker,et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations , 2001, Neurology.
[12] S. Majumder,et al. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation , 2000, Immunological reviews.
[13] P. Matthews,et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. , 2000, Brain : a journal of neurology.
[14] Hans Lassmann,et al. Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.
[15] H. Lassmann,et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.
[16] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[17] Ganter,et al. Spinal cord axonal loss in multiple sclerosis: a post‐mortem study , 1999, Neuropathology and applied neurobiology.
[18] H. Lassmann,et al. Axonal Pathology in Multiple Sclerosis. A Historical Note , 1999, Brain pathology.
[19] M. Cuzner,et al. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system , 1999, Journal of Neuroimmunology.
[20] M Filippi,et al. Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.
[21] A. Luster,et al. Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.
[22] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[23] P M Matthews,et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.
[24] M. Esiri,et al. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. , 1997, Brain : a journal of neurology.
[25] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[26] G. Barker,et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.
[27] C. Raine,et al. The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.
[28] T Revesz,et al. Multiple sclerosis. Pathology of recurrent lesions. , 1993, Brain : a journal of neurology.
[29] D. Paty,et al. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.
[30] E. Cho,et al. Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .
[31] E. Cho,et al. Multiple sclerosis: remyelination of nascent lesions. , 1993, Annals of neurology.
[32] J. Coyle,et al. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies , 1991, Neuroscience.
[33] M. Esiri,et al. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis , 1983, Journal of the Neurological Sciences.
[34] E. Reinherz,et al. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. , 1983, Science.
[35] Dr. med. Hans Lassmann. Comparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis , 1983, Schriftenreihe Neurologie / Neurology Series.
[36] S. Mörk,et al. IN‐SITU CHARACTERIZATION OF MONONUCLEAR CELL INFILTRATES IN LESIONS OF MULTIPLE SCLEROSIS , 1982, Neuropathology and applied neurobiology.
[37] M. Esiri. IMMUNOGLOBULIN-CONTAINING CELLS IN MULTIPLE-SCLEROSIS PLAQUES , 1977, The Lancet.
[38] F. Roncaroli,et al. Neuropathology of multiple sclerosis , 2012 .
[39] L. Sternberger,et al. THE UNLABELED ANTIBODY ENZYME METHOD OF IMMUNOHISTOCHEMISTRY PREPARATION AND PROPERTIES OF SOLUBLE ANTIGEN-ANTIBODY COMPLEX (HORSERADISH PEROXIDASE-ANTIHORSERADISH PEROXIDASE) AND ITS USE IN IDENTIFICATION OF SPIROCHETES , 1970, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[40] B. Brownell,et al. The distribution of plaques in the cerebrum in multiple sclerosis , 1962, Journal of neurology, neurosurgery, and psychiatry.
[41] H. Ris,et al. ULTRASTRUCTURAL STUDY OF REMYELINATION IN AN EXPERIMENTAL LESION IN ADULT CAT SPINAL CORD , 1961, The Journal of biophysical and biochemical cytology.
[42] T. Fog. TOPOGRAPHIC DISTRIBUTION OF PLAQUES IN THE SPINAL CORD IN MULTIPLE SCLEROSIS , 1950 .
[43] A. Blalock. Surgical treatment of pulmonary stenosis. , 1947, Lancet.
[44] T. Rivers,et al. OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS , 1933, The Journal of experimental medicine.
[45] G. Steiner. Krankheitserreger und Gewebsbefund bei Multipler Sklerose: Vergleichend-Histologisch-Parasitologische Untersuchungen bei Multipler Sklerose und Anderen Spirochätosen , 1931 .
[46] J. Baló. ENCEPHALITIS PERIAXIALIS CONCENTRICA , 1928 .
[47] Boris Doinikow. Über De- und Regenerationserscheinungen an Achsenzylindern bei der multiplen Sklerose , 1915 .
[48] A. Jakob. Zur Pathologie der diffusen infiltrativen Encephalomyelitis in ihren Beziehungen zur diffusen und multiplen Sklerose , 1915 .
[49] A. Jakob,et al. Zur pathologie der multiplen sklerose mit besonderer berücksichtigung der akuten formen , 1913 .
[50] F. Wohlwill,et al. Multiple nicht eitrige Encephalomyelitis und multiple Sklerose , 1912 .
[51] E. Müller. Pathologische Anatomie und Pathogenese , 1910 .